Preliminary Results of Prostate Vaporization in the Treatment of Benign Prostatic Hyperplasia by Using a 200-W High-intensity Diode Laser

Urology

Volumn 75, Issue 3, 2010, Pages 658-663

  Chen, Chien Hsu ^a   Chiang, Po Hui ^a   Chuang, Yao Chi ^a   Lee, Wei Ching ^a   Chen, Yen Ta ^a   Lee, Wei Chia ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLADDER OBSTRUCTION; CATHETERIZATION; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTOSCOPY; DIODE LASER; EPIDIDYMITIS; ERECTILE DYSFUNCTION; FOLLOW UP; HEMATURIA; HUMAN; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; QUALITY OF LIFE; RESIDUAL URINE; SAFETY; SCORING SYSTEM; SCROTUM DISORDER; STRESS INCONTINENCE; THERAPY EFFECT; TISSUE NECROSIS; TRANSURETHRAL RESECTION; URETHRA STRICTURE; URGE INCONTINENCE; URINARY TRACT INFECTION; VAPORIZATION;

AGED; FEASIBILITY STUDIES; HUMANS; LASERS, SEMICONDUCTOR; MALE; PROSTATIC HYPERPLASIA; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME;

EID: 77649183270     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.09.033     Document Type: Article

References (29)

1. Madersbacher S., Alivizatos G., Nordling J., et al. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 46 (2004) 547-554
2. Kaplan S.A. AUA guidelines and their impact on the management of BPH: an update. Rev Urol 6 suppl 9 (2004) S46-S52
3. Costello A.J., Bowsher W.G., Bolton D.M., et al. Laser ablation of the prostate in patients with benign prostatic hypertrophy. Br J Urol 69 (1992) 603-608
4. Wendt-Nordahl G., Huckele S., Honeck P., et al. 980-nm diode laser: a novel laser technology for vaporization of the prostate. Eur Urol 52 (2007) 1723-1728
5. Gupta N., Sivaramakrishna, Kumar R., et al. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g. BJU Int 97 (2006) 85-89
6. Elzayat E.A., and Elhilali M.M. Holmium laser enucleation of the prostate (HoLEP): long-term results, reoperation rate, and possible impact of the learning curve. Eur Urol 52 (2007) 1465-1472
7. Seki N., Mochida O., Kinukawa N., et al. Holmium laser enucleation for prostatic adenoma: analysis of learning curve over the course of 70 consecutive cases. J Urol 170 (2003) 1847-1850
8. Reich O., Bachmann A., Siebels M., et al. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 173 (2005) 158-160
9. Te A.E., Malloy T.R., Stein B.S., et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 172 (2004) 1404-1408
10. Ruszat R., Wyler S., Seifert H.H., et al. Photoselective vaporization of the prostate: subgroup analysis of men with refractory urinary retention. Eur Urol 50 (2006) 1040-1049
11. Bachmann A., Ruszat R., Wyler S., et al. Photoselective vaporization of the prostate: the basel experience after 108 procedures. Eur Urol 47 (2005) 798-804
12. Reich O., Bachmann A., Schneede P., et al. Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol 171 (2004) 2502-2504
13. Bachmann A., Schürch L., Ruszat R., et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 48 (2005) 965-972
14. Volkan T., Ihsan T.A., Yilmaz O., et al. Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate. Eur Urol 48 (2005) 608-613
15. Spaliviero M., Araki M., and Wong C. Short-term outcomes of GreenLight HPS laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH). J Endourol 22 (2008) 2341-2347
16. Woo H., Reich O., Bachmann A., et al. Outcome of Greenlight HPS 120-W laser therapy in specific patient populations: those in retention, on anticoagulants, and with large prostates (80 ml). Eur Urol suppl 7 (2008) 378-383
17. Ruszat R., Seitz M., Wyler S.F., et al. Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia. BJU Int 104 (2009) 820-825
18. Ruszat R., Seitz M., Wyler S.F., et al. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 54 (2008) 893-901
19. Seitz M., Ackermann A., Gratzke C., et al. Diode laser. Ex vivo studies on vaporization and coagulation characteristics. Urologe A 46 (2007) 1242-1247
20. Muschter R. Free-beam and contact laser coagulation. J Endourol 17 (2003) 579-585
21. Shah H.N., Sodha H.S., Kharodawala S.J., et al. Influence of prostate size on the outcome of holmium laser enucleation of the prostate. BJU Int 101 (2008) 1536-1541
22. Kumar S.M. Rapid communication: holmium laser ablation of large prostate glands: an endourologic alternative to open prostatectomy. J Endourol 21 (2007) 659-662
23. Rassweiler J., Teber D., Kuntz R., et al. Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention. Eur Urol 50 (2006) 969-980
24. Xia S.J., Zhuo J., Sun X.W., et al. Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 53 (2008) 382-389
25. Seitz M., Reich O., Gratzke C., et al. High-power diode laser at 980 nm for the treatment of benign prostatic hyperplasia: ex vivo investigations on porcine kidneys and human cadaver prostates. Lasers Med Sci 24 (2009) 172-178
26. Han K.R., and Belldegrun A.S. Third-generation cryosurgery for primary and recurrent prostate cancer. BJU Int 93 (2004) 14-18
27. Chuang Y.C., Chiang P.H., Huang C.C., et al. Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates. Urology 66 (2005) 775-779
28. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol 170 (2003) 530-547
29. Te A.E., Malloy T.R., Stein B.S., et al. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int 97 (2006) 1229-1233